Table 2 IHC examination of MIB-1 and BRCA1 expression in OEIs of certain menopausal status and menstrual cycle phase
From: BRCA1 expression, proliferative and apoptotic activities in ovarian epithelial inclusions
| Â | MIB-1 | BRCA1 | ||
|---|---|---|---|---|
| Â | Negative | Positive (%) | Negative | Positive (%) |
Premenopausal | 6 | 7 (54%) | 9 | 4 (31%) |
Postmenopausal | 10 | 7 (41%) | 13 | 4 (24%) |
Total | 16 | 14 (47%) | 22 | 8 (27%) |
Proliferative phase | 3 | 5 (63%) | 5 | 3 (38%) |
Secretory phase | 3 | 2 (40%) | 4 | 1 (20%) |
Total | 6 | 7 (54%) | 9 | 4 (31%) |